Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lindsey Behlman"'
Autor:
Roy S Herbst, Vamsidhar Velcheti, Mari Mino-Kenudson, Matthew D Hellmann, David L Rimm, Kurt A Schalper, Anant Madabhushi, Justin Gainor, Germán Corredor, Miguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, Ila J Datar, Cristian Barrera, Lindsey Behlman, Jonathan W Riess
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/dd6140760c244b16852a5797f0cd5927
Autor:
Miguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, Ila J Datar, Mari Mino-Kenudson, German Corredor, Cristian Barrera, Lindsey Behlman, David L Rimm, Roy S Herbst, Anant Madabhushi, Jonathan W Riess, Vamsidhar Velcheti, Matthew D Hellmann, Justin Gainor, Kurt A Schalper
Publikováno v:
Journal for immunotherapy of cancer. 10(6)
BackgroundTumor infiltrating lymphocytes (TILs) reflect adaptive antitumor immune responses in cancer and are generally associated with favorable prognosis. However, the relationships between TILs subsets and their spatial arrangement with clinical b
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Autor:
Lukas Ronner, Angela G. Fleischman, Ruben A. Mesa, Matthew Chiaramonte, John Mascarenhas, Jason Gotlib, Revathi Kollipara, Mark L. Heaney, Mahta Salehi, Jenny Nguyen, Megan Randall, Cecelia Perkins, Douglas Tremblay, Robyn M. Scherber, Olivia Siwoski, Casey O'Connell, Nikolai A. Podoltsev, Annie Kwok Hung, Lindsey Behlman, Kimia Ziadkhanpour, Andrew T. Kuykendall, Shelby Meckstroth, Ami Dave, Erin Moshier, Jamile M. Shammo, Ronald Hoffman, Michelle Janania Martinez, Mitchell Harrison, Sagar Patel, Paola Fernandez Soto, Michael P. Grant, Hellen Nguyen, Abdulraheem Yacoub
Publikováno v:
Blood. 135:1696-1703
There are unresolved questions regarding the association between persistent leukocytosis and risk of thrombosis and disease evolution in polycythemia vera (PV), as much of the published literature on the topic does not appropriately use repeated-meas
Autor:
Miguel Lopez de Rodas Gregorio, Venkata Nagineni, Arvind Ravi, Ila J. Datar, Mari Mino-Kenudson, German Corredor, Cristian Barrera, Lindsey Behlman, David L. Rimm, Roy S. Herbst, Anant Madabhushi, Jonathan W. Riess, Vamsidhar Velcheti, Matthew Hellmann, Justin F. Gainor, Kurt A. Schalper
Publikováno v:
Cancer Research. 82:1722-1722
The rapid clinical expansion of immune checkpoint blockers (ICB) has transformed the therapeutic arsenal for non-small cell lung cancer (NSCLC). However, only a relatively small fraction of patients benefits from these treatments and those who respon
Autor:
Casey O'Connell, Matthew Chiaramonte, Robyn M. Scherber, Andrew T. Kuykendall, Nikolai A. Podoltsev, Ruben A. Mesa, Jason Gotlib, Mark L. Heaney, Shelby Meckstroth, Lukas Ronner, Lindsey Behlman, John Mascarenhas, Kimia Ziadkhanpour, Jamile M. Shammo, Douglas Tremblay, Abdulraheem Yacoub, Erin Moshier, Ronald Hoffman, Cecelia Perkins, Angela G. Fleischman
Publikováno v:
Blood. 134:2949-2949
Background: There are unresolved questions regarding the association between leukocytosis and risk of thrombosis and disease evolution in polycythemia vera (PV). Published literature on this topic suffers from several key limitations: first "leukocyt